CUSIP 45720N103COMINBXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
136 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Perceptive Advisors LLC | 1.45M | $114.76M | +125.0K | Added |
| 2 | Viking Global Investors LP | 1.44M | $113.58M | −350.0K | Reduced |
| 3 | Morgan Stanley | 1.17M | $92.25M | +724.9K | Added |
| 4 | Sanofi | 1.16M | $91.48M |
| Held |
| 5 | Hightower Advisors, LLC | 870.5K | $68.77M | −1.3K | Reduced |
| 6 | Blackrock, Inc. | 777.4K | $61.41M | +92.6K | Added |
| 7 | Vanguard Group Inc | 623.1K | $49.22M | +28.2K | Added |
| 8 | Sofinnova Investments, Inc. | 454.7K | $35.92M | +14.6K | Added |
| 9 | Capital Research Global Investors | 421.6K | $33.30M | +421.6K | New |
| 10 | State Street Corp | 375.0K | $29.62M | +171.0K | Added |
See every fund holding Inhibrx Biosciences Inc, with full quarter-over-quarter share changes.
Unlock all holders